2015-26563. National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meetings

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Arthritis and Musculoskeletal and Skin Diseases Special Emphasis Panel.

Date: November 3, 2015.

Time: 1:00 p.m. to 3:00 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6701 Democracy Blvd., Bethesda, MD 20892, (Virtual Meeting).

Contact Person: Yin Liu, Ph.D., MD, Scientific Review Officer Scientific Review Branch National Institute of Arthritis, and Musculoskeletal and Skin Diseases, National Institute of Health Bethesda, MD 20892, 301-496-0505, [e-mail].

Name of Committee: National Institute of Arthritis and Musculoskeletal and Skin Diseases Special Emphasis Panel.

Date: November 4, 2015.

Time: 9:00 a.m. to 1:30 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6701 Democracy Blvd., Bethesda, MD 20892, (Virtual Meeting).

Contact Person: Yin Liu, Ph.D., MD, Scientific Review Officer Scientific Review Branch National Institute of Arthritis, and Musculoskeletal and Skin Diseases National Institute of Health Bethesda, MD 20892, 301-496-0505, [e-mail].

(Catalogue of Federal Domestic Assistance Program Nos. 93.846, Arthritis, Musculoskeletal and Skin Diseases Research, National Institutes of Health, HHS)

Dated: October 14, 2015.

Melanie J. Gray,

Program Analyst, Office of Federal Advisory Committee Policy.